8-KEarnings & ResultsExhibits & Filings

GE HealthCare Technologies Inc. 8-K Report, Financial Results (Jul 31, 2024)

Filed July 31, 2024For Securities:GEHC

Summary

GE HealthCare Technologies Inc. (GEHC) has filed an 8-K on July 31, 2024, primarily to announce its second quarter 2024 financial results via an accompanying press release (Exhibit 99). While the 8-K itself does not contain detailed financial figures, it directs investors to the press release for the comprehensive results. This filing signifies the company's adherence to disclosure requirements regarding significant corporate events, in this case, the release of quarterly earnings. Investors should refer to the furnished press release for specifics on revenue, profitability, segment performance, and any forward-looking guidance. This report is typical for companies announcing quarterly earnings and serves as a formal notification to the market. The key information for investors will be within the press release itself, which is expected to detail GEHC's operational and financial performance for the second quarter of 2024. Investors interested in GEHC's current financial standing and outlook should seek out this press release for a complete understanding of the reported results and any management commentary provided.

Key Highlights

  • 1GE HealthCare Technologies Inc. (GEHC) filed an 8-K on July 31, 2024.
  • 2The primary purpose of the filing is to announce the company's second quarter 2024 financial results.
  • 3The detailed financial results are provided in an accompanying press release, furnished as Exhibit 99.
  • 4Investors are directed to the press release for specific financial performance data and commentary.
  • 5The filing serves as a formal notification of the earnings release to the market.
  • 6Information furnished under Item 2.02 is not considered 'filed' for certain legal purposes but is made available to the public.
  • 7Exhibit 104 contains the cover page formatted in Inline XBRL.

Frequently Asked Questions

The specific financial results for GE HealthCare's second quarter of 2024 are detailed in the press release furnished as Exhibit 99 to this Form 8-K filing. You should refer to that document for comprehensive information.

This statement means that while the information is being provided to the public, it is not subject to the same legal liabilities under Section 18 of the Securities Exchange Act of 1934 as if it were formally 'filed' as part of the registration statement. It also means it will not be automatically incorporated by reference into other GEHC filings unless specifically stated.

No, this Form 8-K filing itself does not contain the specific revenue or earnings per share figures for Q2 2024. It only announces that the results have been released and directs investors to the accompanying press release (Exhibit 99) for these details.

Exhibit 104 is the cover page of the Form 8-K, formatted in Inline XBRL. Inline XBRL (eXtensible Business Reporting Language) is a standardized format that makes financial data easier for computers to read and analyze, improving transparency and accessibility for investors and regulators.